Strata Critical Medical (SRTA) Operating Expenses (2019 - 2026)

Strata Critical Medical has disclosed Operating Expenses across 8 years of filings, most recently posting $17.1 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 34.17% year-over-year to $17.1 million; the TTM figure through Mar 2026 stood at $64.9 million (up 6.38% YoY), while the FY2025 annual figure was $63.5 million, up 21.81% from the prior year.
• Operating Expenses climbed to $17.1 million in Q1 2026, from -$82.8 million in the prior quarter.
• Over the last five years, Operating Expenses for SRTA reached as high as $83.1 million in Q4 2023 and fell as low as -$82.8 million in Q4 2025.
• The 5-year median for Operating Expenses is $54.9 million (2025), against an average of $30.9 million.
• Annual changes were most pronounced in 2023 — Operating Expenses surged 1003.57% — and 2024, when it plunged 190.16%.
• A 5-year view of Operating Expenses shows it stood at -$8.1 million in 2022, then soared by 1125.94% to $83.1 million in 2023, then sank by 190.16% to -$74.9 million in 2024, then slipped by 10.52% to -$82.8 million in 2025, then surged by 120.64% to $17.1 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $17.1 million, -$82.8 million, and $54.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.